Key statistics
As of last trade Edwards Lifesciences Corp (EW*:MEX) traded at 1,406.00, -14.59% below its 52-week high of 1,646.17, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,406.00 |
---|---|
High | 1,406.00 |
Low | 1,406.00 |
Bid | -- |
Offer | -- |
Previous close | 1,406.00 |
Average volume | 252.00 |
---|---|
Shares outstanding | 589.80m |
Free float | 584.39m |
P/E (TTM) | 29.72 |
Market cap | 41.51bn USD |
EPS (TTM) | 2.37 USD |
Data delayed at least 20 minutes, as of Nov 19 2024 17:20 GMT.
More ▼
Press releases
- Data Presented at TCT Reinforce Edwards Lifesciences’ Commitment to Structural Heart Innovation
- TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
- Groundbreaking Data Demonstrate Superiority of EARLY TAVR in Asymptomatic Severe Aortic Stenosis Patients
- Edwards Lifesciences Reports Third Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
- Edwards Lifesciences Completes Sale of Critical Care
- CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
More ▼